chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Covid symptoms started on approximately 09/03/2022; tested positive on 09/07/2022. Before testing positive I had symptoms of stuffy head and a little hotness behind eyes. I thought it was a sinus infection because I often get those when I am flying. I had a cough which was for the most part not productive but sometimes quite strong. That was the worst of it but by the time I tested positive the symptoms had moderated somewhat and I tested positive and they immediately gave me a regimen of PAXLOVID so I started that and a couple of days later I flew home and I eventually after a day or two I tested negative. Symptoms lasted about 10 days. I have a lingering cough, but I don't know if it's from the Covid or allergies and occasionally a dripping nose but it's hard to tell if it's from the weather or not.
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048221A and 939902) for COVID-19 prophylaxis.     The patient's past medical history included Hysterectomy (partial) in 2014. Previously administered products included for Product used for unknown indication: Pfizer (EN6204) on 26-Mar-2021 and Pfizer (EWaSO) on 17-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. Concurrent medical conditions included High cholesterol (05-Unk-2005, Under control w/current medications) and Endometriosis (In 2014 partial hysterectomy & Noretindrone until 6/23 kept it at bay until approx. 2 weeks after 9/27/23 booster) since 1997.   On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-May-2022, SARS-CoV-2 test: Positive.         No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2023-746576 (Patient Link).
This study case was received from the investigator on 04 June 2012. A subject received the following vaccinations on 15 February 2012: an injection of ACAM2000 (lot number not reported), TYPHIM Vi (lot number not reported), anthrax (manufacturer and lot number not reported) and hepatitis B (manufacturer and lot number not reported). On 26 February 2012, the subject was diagnosed with unspecified disease of pericardium. Medical history was not reported. The outcome was not reported. Additional information will be requested from the investigator. There is no reporter causality assessment as this is a safety surveillance study. Documents held by sender: None.
Pain at injected location; This is a spontaneous report from a non-contactable consumer. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL6199) via an unspecified route of administration in the left arm on 13Mar2021 at 12:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included TYLENOL and VITAMIN D (MANUFACTURER UNKNOWN); both from unknown date for unknown indication and unknown if ongoing. On 13Mar2021 at 14:30, the patient experienced pain at injected location. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain at injected location was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Injection site hot to touch, fever, aches, soreness, loss of movement, swelling, rash, tight/hard feeling in thigh.
Patient received 0.25ml dose of Moderna in left arm as a booster dose, boostrix in right arm at 1:00pm. Patient was told to remain in pharmacy for at least 15 minutes after dose and check in with us before leaving the store as per protocol. At approximately 1:15 patient reported that she felt "funny and kind of dizzy, and a little off". I asked patient is she was feeling any swelling of her face lips or tongue or any other way felt off, she reported that she did not. I got her a bottle of water and took her into the counseling room to observe, at which point she reported that she felt "like her tongue was swelling".  She did not have any breathing or swallowing issues. We called 911 and I took her blood pressure which was 133/80 with a pulse of 70. I then contacted her doctor, and he immediately called me back on his personal cell phone. He asked if we had any solu-medrol, but we do not stock injectibles,  and asked that we dispense 40mg of prednisone tablets to be given right away. At this point, the paramedics arrived and they were able to converse with the doctor over my cell phone. I did not dispense the prednisone as the paramedics had solu-medrol in their ambulance. Patient was transported to hospital for further evaluation.
Left leg a throbbing pain started wednesday at 1:30 am on the side of the knee down to about 6 inches; When i walked , my knee would almost buckle; right side of mouth throbbing pain , started saturday night had vaccine in the morning.; This is a spontaneous report from a contactable consumer (reported on himself). A 74-Year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: el9265, Expiry date: Unknown) via an unspecified route of administration, in Left arm on 20Feb2021 at 10:00 AM (at the age of 74-years-old), as a single dose for Covid-19 immunization. The patient did not have any medical history. The patient had no known allergies. The patient received medications within 2 weeks of vaccination included SIMVASTATIN, FENOFIBRATE and vitamins (un-specified). Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. On 20Feb2021 at 11:00 PM, the patient had experienced right side of mouth throbbing pain, started Saturday night had vaccine in the morning. Left leg a throbbing pain started Wednesday at 1:30 am on the side of the knee down to about 6 inches. When he walked, his knee would almost buckle. He was starting to get better, then on 02Mar2021 (on the day of this report), the side of his mouth started throbbing again. He went to the dentist on 25Feb2021, could not find anything wrong dentally. The event resulted in a Doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The outcome of the events of right side of mouth throbbing pain, started Saturday night had vaccine in the morning, Left leg a throbbing pain started Wednesday at 1:30 am on the side of the knee down to about 6 inches and when he walked, his knee would almost buckle was reported as not recovered.   No follow-up attempts were possible. No further information was expected.
Sore/achy arm at injection site for three days.  Extreme tiredness for two days.   Body aches for two days.  Headache for one day.  Chills and fever for one day.   Recovered with taking additional baby aspirin  for headache.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received bnt162b2 (BNT162B2), on 27May2022 as dose 4 (booster), single (Lot number: FJ4989) at the age of 71 years for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "allergy: statin drugs" (unspecified if ongoing); "Previous MDS", start date: Mar2021 (unspecified if ongoing), notes: Previous MDS w 5q deletion-received; "cell tansplant", start date: Mar2021 (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "Drug allergy: Codeine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures included Paxlovid from 12Sep2023 to 17Sep2023 were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
MOTHER STATED 2/25/22 THE CHILD HAD BEEN COMPLAINING A HIS ARM HURTING, BUT THE MOTHER THOUGHT IT WAS THE USUAL VACCINE COMPLAINT.  WHEN MOTHER WAS PREPARING THE CHILD FOR BED ON 2/23/2022 AND REMOVED HIS LONG SLEEVE SHIRT SHE NOTICED REDNESS, SWELLING, HEAT FROM SLIGHTLY ABOVE VACCINE SITE DOWN TO BELOW ELBOW INTO FOREARM.  MOTHER STATE THE SKIN IS VERY TIGHT.  SHE HAD GIVEN THE CHILD BENADRYL, TYLENOL AND IBUPROFEN AND APPLIED HEAT COMPLRESSES.  SHE CONTACTED HER PEDICATRICIAN AND WAS TOLD TO CALL THE HEALTH DEPARTMENT TO DETERMINE WHICH VACCINE WAS GIVEN IN THE LEFT ARM.   MOTHER STATES THE COMPRESSES SEEMED TO HELP IN DECREASING THE TIGHTNESS.  NURSE TOLD THE MOTHER TO BRING THE CHILD TO SEE THE PHYSICIAN ESPECIALLY SINCE THE SKIN IS VERY TIGHT DUE TO SWELLING.  MOTHER WILL FOLLOW UP WITH PEDIATRICIAN TODAY.
gave a dose of mcv4 on 10.28.08 and on 10.30.08
Dizziness, Headache, Myalgia, Fever, Diarrhea,  NauseaVomiting,  INSOMNIA, FATIGUE  Narrative:
Sore achy arm has developed with numbing feeling. At site of injection and down the arm and shoulder.  It was a few days after injection and then came back.  Very strange it?s weeks later.
Awakened from sleep, extremely cold, teeth chattering and shivering at 02:30  Returned to bed covered up with more blankets.  Upon wakening, felt felt totally exhausted and weak. I slept and took naps throughout the day.  Some aches in the body and sore arm where injection was given.  Continued to feel extremely weak and cold the next 24 hours.  Felt better day after but still tired and weak. injectgion site reddened and sore.  Injetion site still sensitive, rpink discoloration and lump under the skin
None. Parent notified - Tdap valid according to book. Child will come get polio.
Shingles rash broke out on neck.  Saw doctor on 08/11/2016, and was given Acyclovir 800mg five times a day (number 35).
Information has been received from a physician concerning a 42 year old male who on 9/19/01 was vaccinated with the 1st dose of Hep-A virus vaccine inactivated. On 9/25/01, the pt experienced "fever of 103F, chills and headache". A dx of hepatitis was made. The pt sought unspecified medical attention. FOLLOW-UP Information, received 10/12/2001, indicated that the patient was "doing much better", had less jaundice, and his laboratory values had improved. On 10/04/2001 and 10/09/2001, bilirubin was 65 and ALT was 229. respectively. Upon internal review, hepatitis was determined to be an other important medical event. F/U information received on 10/29/01 from a physician indicated that the pt did not have a reaction to Hep-A vaccine. It was reported that the pt started to have some symptoms at the time of vaccination. The physician felt as though the pt was already infected and that the vaccination was coincidental. It was noted that the pt was doing 'well'. The reporter felt hepatitis was not related to therapy with Hep-A vaccine. F/U information indicated that the onset of the pt's symptoms preceded the start of the therapy with Vaqta. Therefore, WAES01100385 is being deleted from our files on Vaqta.
1 wk p/shot feet cramping over body, tried to relax then passed out & observed to look like having convuls; MD said had a growth in head;
Information has been received from a physician concerning a 9 year old male patient who on an unspecified date was vaccinated with a dose of VAQTA. The physician reported that the patient received the vaccine and fainted. The physician stated that after 2 minutes the patient was fine and recovered. No further information is available.
Patient received Proquad and Kinrix on 3/18/22. Mom reported large red area at injection site which improved with time. At visit on 3/23/22 mild redness at patients upper right anterior/lateral thigh. No further treatment needed
I woke up with a severe headache bordering on a migraine and had severe fatigue where I was sleeping 12 hours a day. This lasted 4.5 days. The morning of the 5th day I woke up with vertigo and nausea. Currently I still have the vertigo and nausea.
low grade fevers to 100 F; diffuse myalgia; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fevers to 100 F), MYALGIA (diffuse myalgia) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PYREXIA (low grade fevers to 100 F), MYALGIA (diffuse myalgia) and FATIGUE (fatigue). On 22-Jan-2021, PYREXIA (low grade fevers to 100 F), MYALGIA (diffuse myalgia) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
On my right forearm the blood vessels burst purpura. It was not painful at all but it just looked terrible. It continued happening so it happened about thirteen times. Now it is happening on both forearms. Sometimes it can be pretty extreme and sometimes pretty mild.  The bloodwork only showed a vitamin B12 deficiency.
spontaneous hives to entire body for 24 hours 4 days after 2nd vaccination
Pt states he received vaccine on 10/11/18 and starting on 10/12/18 he developed cold chills and low grade fever. States the night of 10/12/18 he had a fever of 101.2, chills, body aches, and sweating. States this has continued for 3 days.
This spontaneous report as received from a 54 year old female nurse (reporting on herself), with a pertinent medical history of low platelets and upper respiratory infection. On 03-MAY-2013 the patient was vaccinated with the second dose of ZOSTAVAX (Lot # not reported) (dose and route not reported) for shingles vaccination. Concomitant therapy was not reported. On 28-MAY-2013, the patient started to feel pain and developed an outbreak of shingles on the left side of her hip after receiving the second shot of ZOSTAVAX. it was unspecified when the patient received the first shot of ZOSTAVAX. The patient sought unspecified medical attention and LYRICA (dosage and manufacturer unspecified) was given as a treatment for the adverse events. The patient recovered from shingles and pain on an unspecified date. Additional information has been requested.
Body aches beginning in the middle of the night, in process of subsiding now but back and body is still sore Intense itching/burning of hands and feet, beginning about midnight and waking me about every twenty minutes until dawn.  Gone now.
PT states he had Moderna covid booster administered on Friday, 12/3/21 and experienced swelling of lymph nodes, and it has not gone away since then. He says it seems it has gotten a little better as of today, 12/6/21.
patient received first dose of covid vaccine, patient started having hives and red rash on left arm on cheeks. Started about 15 minutes after dose. patient received 50mg dose of benadryl which subsided reaction.
Flu-like (fever,  chills, body aches, headaches, cough, congestion, diarrhea)
Received vaccine 5/20/04 and developed pain on 6/2/04. Described as mild by mother: (20 spots, sibling with chicken pox reported 5/19/04 as onset date. To defer second dose of Varivax.
Information has been received from an office manager concerning a 42 year old female registered nurse who on Oct 11 2004 was exposed to pneumococcal 23v polysaccharide vaccine (lot 647654/0865N). the nurse entered into the vial, then when she was pulling the syringe out of the vial the vaccine sprayed out and got into her eye, The nurse's eye closed up, she had swelling in her face and she was short of breath. the nurse's eye was washed out. On Oct 12 2004 the nurse was seen by a physician in the office and no vision problems were noted. The nurse was reportedly recovering. It was also reported that another nurse had pulled a syringe out of the same vial and was sprayed on her hand (WAES0410USA01354). Additional information has been requested.
3hr p/vax sore arm;next day sore arm & stiff neck on rt;missed 6hr work on Friday 5DEC97;took non steroidal anti inflam;referred to PMD;
3-24-21 7:06PM PT STATES 'CHEST TIGHT/PRESSURE, SOB, NAUSEA & LIGHT HEADED'.  A/O, W/D, RESP REG WITH EASE. NO DIFFICULTY SWALLOWING. NO ACUTE/OBVIOUS DISTRESS. 7:15 AMBU TO BATHROOM.  7:26PM STATES SHE 'FEELS BETTER AND OK TO GO HOME'. AMBULATORY TO EXIT - GAIT BRISK AND STEADY. RESP REG WITH EASE. NO DISTRESS NOTED. 3-25-21 8:15 TC: PT STATES SHE IS 'ALL BETTER TODAY'.
The patient experienced mild pruritic rash on chest with out compromised breathing about 20 minutes after the vaccine.  The rash resolved and the patient left on their own accord.
Approximately 6 days after vaccine, experienced Covid symptoms. Mostly headaches and loss of taste and smell. Cannot smell garlic, vinegar, onion, anything. Cannot taste anything at all. Went and got a Covid test and it was negative.
1 of 2 pts vaxed from the same lot# who devel erythema, induration, swelling & fever (unmeasured) p/vax;pt had onset 12-24hrs p/vax;marked induration 10-15cm (entire thigh);acute phase @ 5days;rx APAP/warm compresses;resolved over 3wks
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' pertinent medical history, concomitant medications and drug reactions or allergies reported. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ oral liquid, lot # L033545, expiration date 30-MAY-2017 (dose was not specified). No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
After 3 hrs, he was nausea, fast heart rate, chest tight. He likes he's going to pass out. Slept for 8 hrs. He had chest tightness for 3 days.
No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 35-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients).    No concomitant medication details was reported. No treatment medication details was reported.
Patient's mom wrote that patient was "14" but the DOB written on form makes the patient only 11yo. The patient is underage and therefore the vaccination was not given in accordance to the approved EUA guidelines.
Patient seen in the ED and brought in by EMS on 11/27 for weakness, confusion, nonproductive cough, and sore throat. COVID PCR test done in the ED returned positive. Patient admitted 11/27/22 - 11/29/22 for COVID-19. Patient denied any shortness of breath and did not require any supplemental O2.
Memory Loss. It started about 10 days after 1st dose. It is not brain fog, it is complete memory loss of a conversation, information etc. it has been coming and going, some situations worse than others.
Patient is a 29 y.o. year-old female that presented to the clinic today for a Moderna COVID-19 vaccine.  Moderna COVID-19 vaccine was administered at: Time: 1820       Date: 1/8/2021   Patient presented with symptoms at time 1837.  Patient's symptoms include the following:   Skin and Mucosal symptoms: Yes: Swelling of the throat and nose. Patient states that her nose started to feel funny and her throat was tight. She also noticed that her arm was red and swollen.    Respiratory Symptoms: No   Gastrointestinal Symptoms: No   Cardiovascular: No   The following actions were performed: Bendaryl 25mg administered as a single dose, patient brought to exam room by RN & MA.  Vitals taken every 5 minutes while monitoring patient condition. At 1849 patient reported that her throat was feeling better. Patient had a localized reaction at the site of injection Left upper arm including redness, swelling and warm to touch.  At 1903 RN reevaluated patient and reports that her redness is decreasing in her left arm and the throat/nose numbness was getting better. PA-C came into the room and evaluated patient. She said she sounds good and did not appear to be in distress. Patients husband drove her home after patient was monitored for approximately 40 minutes. Prior to patient leaving clinic RN advised patient of the 911/emergency room protocol .  Patient verbalized understanding and was escorted out by RN to her car.   Incident reported to VAERS and database report completed   1/8/2021
Dizziness, Myalgia, Arthralgia, SkinRash, Purpura, Palpitations, leg swelling, leg pain Narrative: Employee relates to chest pain, shortness of breath, she was evaluated at ER, ACS ruled out discharged same day. 08/17/21, she related to pain the foot/leg swelling, bruises at the upper arm
Information has been received from a physician concerning a 4 year old male with asthma and eczema and no known drug reactions/allergies who on 23-JUL-2008 afternoon was vaccinated in right arm with the second dose of VARIVAX (LOT# 661443/0528X) and was also vaccinated with the second dose of MMR II (LOT# 656864/0412U) in the same arm. Other vaccinations included IPOL (unspecified) (WYETH - LOT# A0126) and INFANRIX (LOT# AC14B067BA) in the other arm. Other concomitant therapy included montelukast sodium. There was no illness at time of vaccination. On 28-JUL-2008 the patient developed vesicular rash at sites of eczema. On 29-JUL-2008 the patient returned to clinic and presented with an itchy rash in the eczema area and in the bend of the same arm he received the VARIVAX. The patient was prescribed acyclovir (manufacturer unspecified), BENADRYL and standard topical steroid cream. The patient was consulted with dermatologist. The patient's symptoms persisted. The patient was held out of daycare. Vesicular pruritic rash at sites of eczema was considered to be disabling. Additional information has been requested.